Long-Term Study Shows Nivolumab Protects Melanoma Patients for Nearly a Decade

A large international study has brought good news for people battling melanoma, the deadliest form of skin cancer. Researchers found that the drug nivolumab, given after surgery to remove advanced melanoma, can help keep the disease from coming back for many years—much longer than another widely used treatment, ipilimumab.

The results come from the Check…